1) 非営利機関以外の利用者は事前に<a href= 'http://ips-cell.net/j/index.php' target="_blank">iPSアカデミアジャパン株式会社 </a>から確認書を得ること。2) <a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/non-profit.pdf' target="_blank">別紙1 (非営利) </a>または<a href='http://cell.brc.riken.jp/ja/wp-content/uploads/restriction/profit.pdf' target="_blank">別紙1 (営利) </a>を提供同意書 (C-0003またはC-0003p) に添付すること。3) 利用者は、事前に承諾者から承諾を得ること。4) 先ずは、<a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line 問い合わせ&">理研細胞バンク</a>にお問い合わせください 。
疾患特異的iPS細胞株。脊髄小脳変性症患者由来。HPS0422, HPS0424は同一人由来。<a href='https://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。
1) In relation to the for-profit organizations, please contact <a href= 'http://ips-cell.net/e/index.php' target="_blank">iPS Academia Japan, Inc.</a>, prior to the utilization of iPS cells. 2) Attach <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/non-profit_en.pdf' target="_blank">TERMS and CONDITIONS (non-for-profit) </a> or <a href='http://cell.brc.riken.jp/en/wp-content/uploads/restriction/profit_en.pdf' target="_blank">TERMS and CONDITIONS (for-profit) </a> to MTA (C-0007 or C-0007p) . 3) The RECIPIENT agrees to obtain the prior written approval of the distribution from the APPROVER. 4) Contact Us : <a href="mailto:cellips.brc@riken.jp?subject=Disease specific iPS cell line&">RIKEN Cell Bank</a>
HPS0422
HPS0422
Disease specific iPS cell line derived from a patient : Spinocerebellar Degeneration.
疾患特異的iPS細胞株。脊髄小脳変性症患者由来。HPS0422, HPS0424は同一人由来。<a href='http://cell.brc.riken.jp/ja/manual/vitrification' target="_blank">ガラス化法（Vitrification法）</a>保存。